L. Altomonte

1.2k total citations
69 papers, 879 citations indexed

About

L. Altomonte is a scholar working on Rheumatology, Epidemiology and Surgery. According to data from OpenAlex, L. Altomonte has authored 69 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Rheumatology, 16 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in L. Altomonte's work include Liver Disease Diagnosis and Treatment (15 papers), Systemic Lupus Erythematosus Research (14 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). L. Altomonte is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Systemic Lupus Erythematosus Research (14 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). L. Altomonte collaborates with scholars based in Italy, United States and Israel. L. Altomonte's co-authors include A. Zoli, L. Mirone, M Magarò, Giovanni Ghirlanda, Raffaele Manna, Antonio G. Rebuzzi, A. Bertoli, Antonio Greco, Alessandra Galossi and Palma Scolieri and has published in prestigious journals such as The Lancet, Annals of the New York Academy of Sciences and Diabetologia.

In The Last Decade

L. Altomonte

62 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Altomonte Italy 17 320 149 134 127 104 69 879
A. Zoli Italy 18 475 1.5× 71 0.5× 121 0.9× 76 0.6× 112 1.1× 56 952
L. Mirone Italy 16 330 1.0× 51 0.3× 76 0.6× 59 0.5× 82 0.8× 41 696
V. Parameswaran Australia 12 325 1.0× 172 1.2× 105 0.8× 139 1.1× 87 0.8× 16 797
James L. McGuire United States 16 425 1.3× 70 0.5× 56 0.4× 260 2.0× 183 1.8× 22 1.1k
Y Scharf Israel 18 241 0.8× 100 0.7× 297 2.2× 50 0.4× 60 0.6× 54 842
Masato Kimura Japan 20 109 0.3× 192 1.3× 189 1.4× 86 0.7× 165 1.6× 82 1.2k
Morio Kuramochi Japan 17 131 0.4× 56 0.4× 354 2.6× 216 1.7× 144 1.4× 75 1.3k
Yoshiyuki Ozono Japan 19 125 0.4× 103 0.7× 223 1.7× 109 0.9× 255 2.5× 70 1.3k
Inimioara Mihaela Cojocaru Romania 16 376 1.2× 192 1.3× 85 0.6× 38 0.3× 221 2.1× 60 1.1k
Ken Ward United States 13 144 0.5× 107 0.7× 82 0.6× 164 1.3× 357 3.4× 25 1.3k

Countries citing papers authored by L. Altomonte

Since Specialization
Citations

This map shows the geographic impact of L. Altomonte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Altomonte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Altomonte more than expected).

Fields of papers citing papers by L. Altomonte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Altomonte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Altomonte. The network helps show where L. Altomonte may publish in the future.

Co-authorship network of co-authors of L. Altomonte

This figure shows the co-authorship network connecting the top 25 collaborators of L. Altomonte. A scholar is included among the top collaborators of L. Altomonte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Altomonte. L. Altomonte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Altomonte, L., A. Zoli, L. Mirone, et al.. (2009). Stimulatory Effect of Pentagastrin on Growth Hormone and Prolactin Secretion in Normal Subjects. Experimental and Clinical Endocrinology & Diabetes. 88(6). 334–338.
2.
Altomonte, L., et al.. (2009). Impaired Growth Hormone Response to Clonidine in Obesity. Experimental and Clinical Endocrinology & Diabetes. 92(5). 231–234. 1 indexed citations
3.
Andreassi, Catia, A. Zoli, Flavia Scuderi, et al.. (2001). Anticardiolipin Antibodies in Patients with Primary Antiphospholipid Syndrome: A Correlation Between IgG Titre and Antibody-Induced Cell Dysfunctions in Neuronal Cell Cultures. Clinical Rheumatology. 20(5). 314–318. 8 indexed citations
4.
Zoli, A., Alessandra Pompa, A. Barini, et al.. (1999). Basal and After‐stimuli Test for Prolactinemia in Systemic Lupus Erythematosus. Annals of the New York Academy of Sciences. 876(1). 155–158. 13 indexed citations
5.
Mirone, L., L. Altomonte, Antonino Raco, et al.. (1998). Cerebral blood flow abnormalities detected by SPECT in Behçet's-syndrome-related psychiatric disorders. Clinical Rheumatology. 17(1). 75–76. 2 indexed citations
6.
Zoli, A., et al.. (1998). Serum zinc and copper in active rheumatoid arthritis: Correlation with interleukin 1? and tumour necrosis factor ?. Clinical Rheumatology. 17(5). 378–382. 79 indexed citations
7.
Mirone, L., et al.. (1997). Behçet's disease and cardiac arrhythmia. Clinical Rheumatology. 16(1). 99–100. 9 indexed citations
8.
Mirone, L., L. Altomonte, P. D’Agostino, et al.. (1996). A study of serum androgen and cortisol levels in female patients with rheumatoid arthritis. Correlation with disease activity. Clinical Rheumatology. 15(1). 15–19. 37 indexed citations
9.
Altomonte, L., A. Zoli, A Veneziani, et al.. (1994). Clinically silent inflammatory gut lesions in undifferentiated spondyloarthropathies. Clinical Rheumatology. 13(4). 565–570. 22 indexed citations
10.
Altomonte, L., A. Zoli, L. Mirone, Palma Scolieri, & M Magarò. (1992). Serum levels of interleukin-1b, tumour necrosis factor-a and interleukin-2 in rheumatoid arthritis. Correlation with disease activity. Clinical Rheumatology. 11(2). 202–205. 58 indexed citations
11.
Magarò, M, et al.. (1991). Generalized osteoporosis in non-steroid treated rheumatoid arthritis. Rheumatology International. 11(2). 73–76. 21 indexed citations
12.
Magarò, M, A. Zoli, L. Altomonte, et al.. (1991). Sensorineural hearing loss in rheumatoid arthritis.. PubMed. 8(5). 487–90. 63 indexed citations
13.
Magarò, M, et al.. (1990). Effect of oral gold salt therapy on bile acid absorption in rheumatoid arthritis patients. Clinical Rheumatology. 9(1). 42–47. 4 indexed citations
14.
Magarò, M, et al.. (1989). BONE GLA PROTEIN (BGP) LEVELS AND BONE TURNOVER IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 28(3). 207–211. 15 indexed citations
15.
Magarò, M, et al.. (1989). Serum osteocalcin as an index of bone turnover in active rheumatoid arthritis and in active psoriatic arthritis. Clinical Rheumatology. 8(4). 494–498. 12 indexed citations
16.
Altomonte, L., A. Zoli, Federica Alessi, et al.. (1987). Effect of Fenfluramine on Growth Hormone and Prolactin Secretion in Obese Subjects. Hormone Research. 27(4). 190–194. 18 indexed citations
17.
Altomonte, L., A. Zoli, Lorenzo Sommella, et al.. (1984). Concentration of serum bile acids as an index of hepatic damage in systemic lupus erythematosus. Clinical Rheumatology. 3(2). 209–212. 3 indexed citations
18.
Altomonte, L., et al.. (1982). [Glucose and insulin in the blood and ascitic fluid after oral administration of glucose in hepatic cirrhosis].. PubMed. 28(2). 133–6. 1 indexed citations
19.
Altomonte, L., et al.. (1982). [Serum gastrin in rheumatoid arthritis].. PubMed. 73(25). 1761–3. 1 indexed citations
20.
Altomonte, L., et al.. (1979). Gastrin response to insulin in patients with cirrhosis of the liver.. PubMed. 26(3). 190–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026